Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
PLoS One. 2011 Jan 24;6(1):e16081. doi: 10.1371/journal.pone.0016081.
Chronic hepatitis C (CH) can develop into liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Liver fibrosis and HCC development are strongly correlated, but there is no effective treatment against fibrosis because the critical mechanism of progression of liver fibrosis is not fully understood. microRNAs (miRNAs) are now essential to the molecular mechanisms of several biological processes. In order to clarify how the aberrant expression of miRNAs participates in development of the liver fibrosis, we analyzed the liver fibrosis in mouse liver fibrosis model and human clinical samples.
In a CCL(4)-induced mouse liver fibrosis model, we compared the miRNA expression profile from CCL(4) and olive oil administrated liver specimens on 4, 6, and 8 weeks. We also measured expression profiles of human miRNAs in the liver biopsy specimens from 105 CH type C patients without a history of anti-viral therapy.
Eleven mouse miRNAs were significantly elevated in progressed liver fibrosis relative to control. By using a large amount of human material in CH analysis, we determined the miRNA expression pattern according to the grade of liver fibrosis. We detected several human miRNAs whose expression levels were correlated with the degree of progression of liver fibrosis. In both the mouse and human studies, the expression levels of miR-199a, 199a*, 200a, and 200b were positively and significantly correlated to the progressed liver fibrosis. The expression level of fibrosis related genes in hepatic stellate cells (HSC), were significantly increased by overexpression of these miRNAs.
Four miRNAs are tightly related to the grade of liver fibrosis in both human and mouse was shown. This information may uncover the critical mechanism of progression of liver fibrosis. miRNA expression profiling has potential for diagnostic and therapeutic applications.
慢性丙型肝炎(CH)可发展为肝硬化(LC)和肝细胞癌(HCC)。肝纤维化和 HCC 的发展密切相关,但由于对纤维化进展的关键机制尚不完全了解,因此尚无有效的纤维化治疗方法。microRNAs(miRNAs)对于几个生物学过程的分子机制至关重要。为了阐明 miRNAs 的异常表达如何参与肝纤维化的发展,我们分析了小鼠肝纤维化模型和人类临床样本中的肝纤维化。
在 CCL(4)诱导的小鼠肝纤维化模型中,我们比较了 CCL(4)和橄榄油给药后 4、6 和 8 周肝组织的 miRNA 表达谱。我们还测量了 105 例无抗病毒治疗史的 CH 型 C 患者肝活检标本中的人类 miRNA 表达谱。
与对照组相比,11 种小鼠 miRNA 在进展性肝纤维化中显著升高。通过对大量 CH 分析中的人类材料进行研究,我们根据肝纤维化的程度确定了 miRNA 的表达模式。我们检测到几种与肝纤维化进展程度相关的人类 miRNA。在小鼠和人类研究中,miR-199a、199a*、200a 和 200b 的表达水平与进展性肝纤维化呈正相关且显著相关。这些 miRNA 的过表达显著增加了肝星状细胞(HSC)中纤维化相关基因的表达水平。
在人和小鼠中,有四个 miRNAs 与肝纤维化的程度密切相关。这些信息可能揭示了肝纤维化进展的关键机制。miRNA 表达谱分析具有诊断和治疗应用的潜力。